R

Royalty Pharma plc

D

RPRX

USD

-0.05

(-0.1772%)

مفتوح الان

20,398.00

حجم التداول

2.3015

الربح لكل سهم

2.94

العائد الربحي

18.797

P/E

12,632,828,563.64

حجم السوق

اليوم

-0.0709%

1 اسبوع

1.403%

1 شهر

3.754%

6 اشهر

-6.174%

12 اشهر

0.751%

بداية السنة

0.320%

كل الوقت

0%

أصول ذات صلة

أفضل المتداولين

Title:
Royalty Pharma plc

Sector:

Healthcare

Industry:

Biotechnology

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا